By using a gentle, patented, and continuous enzymatic hydrolysis process, Biomega turns undervalued, food-grade salmon material (Atlantic Salmon off-cuts) into premium health ingredients.
Biomega Group AS (Bergen, Norway) launched biomegaSalMe Peptides, bioactive salmon peptides in powder form that are neutral in both taste and smell for use in supplements and food concepts. By using a gentle, patented, and continuous enzymatic hydrolysis process, biomega turns undervalued, food-grade salmon material (Atlantic Salmon off-cuts) into premium health ingredients.
“We are delighted to announce the launch of our biomegaSalMe Peptides, which are 100% naturally processed, sustainable, and pure salmon proteins,” Dr. Silke Middendorf, CCO at biomega, said in a press release. “For consumers, they offer superb nutritional value as they are easy to digest and are absorbed by the body faster than intact native proteins. This maximizes nutrient delivery to muscle tissues. They offer additional health benefits—such as maintaining energy and general vitality—due to their valuable Bvitamins, especially vitamin B12. Additionally, they indicate an improved body composition. For our customers, the more neutral taste and smell of our peptides deliver previously untapped potential for health food applications, particularly for innovations in weight management and active nutrition.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.